0
Skip to Content
Rare and Relentless
Home
Ultra Blog
About
Contact
Donations to Keep this going!
Rare and Relentless
Home
Ultra Blog
About
Contact
Donations to Keep this going!
Home
Ultra Blog
About
Contact
Donations to Keep this going!
The Risk of Speaking Up: What Advocacy Really Looks Like
Gillian Hall Sapia 5/7/25 Gillian Hall Sapia 5/7/25

The Risk of Speaking Up: What Advocacy Really Looks Like

I am not interested in being liked by one side or the other. I’m interested in saving lives. And sometimes that means saying the uncomfortable thing, at the uncomfortable time, in the most public way possible.

Read More
Congress Just Asked: Will America Still Lead in Cures? Here’s What They Need to Hear.
Gillian Hall Sapia 5/3/25 Gillian Hall Sapia 5/3/25

Congress Just Asked: Will America Still Lead in Cures? Here’s What They Need to Hear.

Read More
“I Shouldn’t Be Telling You This”: The Secret Dismantling of Rare Disease Advocacy at the FDA
Gillian Hall Sapia 4/22/25 Gillian Hall Sapia 4/22/25

“I Shouldn’t Be Telling You This”: The Secret Dismantling of Rare Disease Advocacy at the FDA

Read More
If You Don’t Speak Up, It Didn’t Happen: Why 4 Republicans Hold Medicaid’s Fate
Gillian Hall Sapia 4/16/25 Gillian Hall Sapia 4/16/25

If You Don’t Speak Up, It Didn’t Happen: Why 4 Republicans Hold Medicaid’s Fate

Read More
Be Louder Than the Chaos: Why Now Is Not the Time to Pause
Gillian Hall Sapia 4/15/25 Gillian Hall Sapia 4/15/25

Be Louder Than the Chaos: Why Now Is Not the Time to Pause

Read More
I Wrote the System Failure Report. Why Do I Still Have to Prove My Daughter’s Pain?
Gillian Hall Sapia 4/14/25 Gillian Hall Sapia 4/14/25

I Wrote the System Failure Report. Why Do I Still Have to Prove My Daughter’s Pain?

Read More
Through the Noise: Rare Disease Still Deserves Equity
Gillian Hall Sapia 4/10/25 Gillian Hall Sapia 4/10/25

Through the Noise: Rare Disease Still Deserves Equity

Read More
This Isn’t Baby Formula—It’s Lifesaving Medicine: How Tariffs and Supply Chain Failures Endanger Kids with Galactosemia
Gillian Hall Sapia 4/9/25 Gillian Hall Sapia 4/9/25

This Isn’t Baby Formula—It’s Lifesaving Medicine: How Tariffs and Supply Chain Failures Endanger Kids with Galactosemia

Read More
Not Just Numbers: The Human Cost of Delayed Rare Disease Therapies
Gillian Hall Sapia 4/6/25 Gillian Hall Sapia 4/6/25

Not Just Numbers: The Human Cost of Delayed Rare Disease Therapies

Read More
Federal Funding Fights: How Lawsuits Are Shaping NIH, FDA, and CMS Futures
Gillian Hall Sapia 4/5/25 Gillian Hall Sapia 4/5/25

Federal Funding Fights: How Lawsuits Are Shaping NIH, FDA, and CMS Futures

Read More
System Failure: $7.8 Million per Galactosmeia Patient in Preventable Burden
Gillian Hall Sapia 4/4/25 Gillian Hall Sapia 4/4/25

System Failure: $7.8 Million per Galactosmeia Patient in Preventable Burden

Read More
The $2.5 Trillion Math Problem That Rare Disease Families Can’t Afford to Ignore
Gillian Hall Sapia 4/1/25 Gillian Hall Sapia 4/1/25

The $2.5 Trillion Math Problem That Rare Disease Families Can’t Afford to Ignore

Read More
How to Contact Congress staffers:
Gillian Hall Sapia 3/22/25 Gillian Hall Sapia 3/22/25

How to Contact Congress staffers:

Read More
Fun Advocacy Ask: Name a Baby Zebra After a Rare Disease Warrior!
Gillian Hall Sapia 3/21/25 Gillian Hall Sapia 3/21/25

Fun Advocacy Ask: Name a Baby Zebra After a Rare Disease Warrior!

Read More
New Year, Same Fight: Why 2025 Demands More Than Hope
Gillian Hall Sapia 3/21/25 Gillian Hall Sapia 3/21/25

New Year, Same Fight: Why 2025 Demands More Than Hope

Read More
Ultra Rare
Gillian Hall Sapia 3/11/19 Gillian Hall Sapia 3/11/19

Ultra Rare

It all begins with an idea.

Read More